Kira and its complement-target inhibitors plot run to the clinic with new investor cash just months ...

Retrieved on: 2021-01-07 16:07:30

Tags for this article:

Click the tags to see associated articles and topics

Kira and its complement-target inhibitors plot run to the clinic with new investor cash just months .... View article details on hiswai:

Excerpt

The complement cascade, a part of the innate immune system, is “great when it's working well,” the CEO told Endpoints News in November.

Article found on: endpts.com